The Trendlines Group Ltd. operates as an enterprise dedicated to bringing innovations to market, simultaneously functioning as a private equity and venture capital firm. Its investment strategy comprehensively covers all company stages, from initial incubation and seed funding to early and late-stage venture capital rounds. The firm allocates capital across a broad spectrum of industries. These include food, environmental (clean) technologies, agricultural technology, and a significant focus on life sciences, particularly medical devices, biotechnology, and pharmaceuticals. They also seek opportunities within security, the wider medical sector, and information technology. Geographically, their investment activities are concentrated in Israel and Singapore. Beyond financial backing, Trendlines offers a comprehensive suite of support services for entrepreneurs. These include fostering new businesses through incubation, developing partnerships and distribution channels, crafting market strategies and business plans, aiding research and development, facilitating commercialization, providing business development expertise, devising financial and funding strategies, delivering administrative support, and managing marketing communications. Typically, the company invests a minimum of $60,000 into its portfolio entities. For exiting investments, Trendlines primarily targets mergers and acquisitions, initial public offerings (IPOs), or other forms of asset divestment. A core part of their operational model involves combining their own capital with government funding to reduce the inherent risks associated with establishing and growing new ventures. They are deeply engaged in every aspect of their portfolio companies, from foundational technological advancements to the overarching business development process. Established in 1993, The Trendlines Group Ltd. maintains its headquarters in M.P. Misgav, Israel, with additional office locations in Tel Aviv, Israel; Beijing, China; and Singapore.